Search For "dcgi"
If govt permits indigenous mRNA vaccine is ready to be roll out in 72 hou
Updated : 23 hours, 1 min ago IST
New Delhi [India], June 29 (ANI): The company is ready to roll out India's first mRNA vaccine in 72 hours after the government's permission, said Gennova Biopharmaceuticals Ltd Chief Executive Officer and Whole-time Director Dr Sanjay Singh.
Read More
India's first mRNA vaccine by Gennova gets DCGI approval, to be rolled out
Updated : 1 day, 4 hours ago IST
Pune (Maharashtra) [India], June 29 (ANI): India's first indigenously developed mRNA vaccine against the COVID-19 gets the Emergency Use Authorization (EUA), to be sold under the brand name GEMCOVAC™-19 and will be rolled out soon, informed the officials on Wednesday.
Read More
SII's Covovax gets DCGI emergency use nod for children between 7-12 years
Updated : 1 day, 23 hours ago IST
New Delhi [India], June 28 (ANI): The Drugs Controller General of India (DCGI) has given restricted emergency use authorisation (EUA) to Pune-based Serum Institute of India's COVID-19 vaccine 'Covovax' for children aged 7 to 12 years, sources told ANI.
Read More
DCGI gives emergency use authorisation to India's first mRNA COVID-19 vacc
Updated : 1 day, 22 hours ago IST
New Delhi [India], June 28 (ANI): The Drugs Controller General of India (DCGI) has approved two doses of Pune-based Gennova Biopharmaceuticals' mRNA COVID-19 vaccine for restricted use in emergency situations for beneficiaries aged above 18 years age group.
Read More
WHO approves Biological E Limited as additional manufacturing site for Joh
Updated : 1 week, 1 day ago IST
New Delhi [India], June 22 (ANI): US Embassy in India congratulated Biological E. Limited, a Hyderabad-based pharmaceutical and vaccines company for getting approval from WHO as an additional manufacturing site for the Janssen/Johnson and Johnson COVID-19 vaccine.
Read More
CBI arrests DCGI official in Rs 4 lakh bribery case
Updated : 1 week, 2 days ago IST
New Delhi [India], June 21 (ANI): The Central Bureau of Investigation (CBI) on Tuesday arrested one Drug Controller General of India (DCGI) official in the national capital for allegedly taking a bribe of Rs 4 lakh.
Read More
Bharat Biotech's COVID-19 nasal vaccine phase III trials completed
Updated : 1 week, 4 days ago IST
Paris [France], June 19 (ANI): Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday (local time) said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data with Drugs Controller General of India (DCG
Read More
DCGI approves Corbevax as first heterologous COVID-19 booster shot for adu
Updated : 3 weeks, 5 days ago IST
Hyderabad (Telangana) [India], June 4 (ANI): Biological E. Limited, a Hyderabad-based pharmaceutical and vaccines company, on Saturday, announced that its Corbevax COVID-19 vaccine has been approved by the Drug Controller General of India (DCGI) as a heterologous COVID-19 booster dose for
Read More
Bharat Biotech seeks DCGI's permission to conduct Covaxin booster trials i
Updated : 1 month, 3 weeks ago IST
New Delhi [India], May 4 (ANI): Hyderabad-based pharma company Bharat Biotech has sought permission from the Drugs Controller General of India (DCGI) to conduct trials of Covaxin as COVID-19 vaccine booster dose in the 2-18 age group, sources said.
Read More
SEC seeks more data from Serum Institute over COVID vaccine Covovax for 7-
Updated : 2 months ago IST
New Delhi [India], April 30 (ANI): The Drugs Controller General of India's (DCGI) subject expert committee on Friday sought more data from Pune based Serum Institute of India (SII) on the Covovax vaccine for the age group of 7-12 years.
Read More
Paediatricians welcome COVID vaccines for kids, say parents mustn't hesita
Updated : 2 months ago IST
New Delhi [India], April 26 (ANI): The Drugs Controller General of India (DCGI) on Tuesday granted an emergency use authorisation (EUA) to Bharat Biotech's Covaxin for the age group of 6-12 years.
Read More
DCGI approves COVID-19 vaccine Covaxin for children aged 6-12
Updated : 2 months ago IST
Hyderabad (Telangana) [India], April 26 (ANI): The Drugs Controller General of India (DCGI) on Tuesday granted an emergency use authorisation (EUA) to Bharat Biotech's Covaxin for the age group of 6-12 years.
Read More
